|
C18ORF25 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.01399999999863E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.967100E-04 |
| Normal-vs-Stage2 |
1.972210E-04 |
| Normal-vs-Stage3 |
2.4676999999973E-05 |
| Normal-vs-Stage4 |
2.20999999999139E-05 |
| Stage1-vs-Stage2 |
5.637200E-01 |
| Stage1-vs-Stage3 |
1.544620E-01 |
| Stage1-vs-Stage4 |
1.636040E-01 |
| Stage2-vs-Stage3 |
6.519200E-01 |
| Stage2-vs-Stage4 |
4.920000E-01 |
| Stage3-vs-Stage4 |
7.989600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.21939999999599E-05 |
| Normal-vs-AfricanAmerican |
2.344000E-02 |
| Normal-vs-Asian |
2.164900E-04 |
| Caucasian-vs-AfricanAmerican |
1.614180E-01 |
| Caucasian-vs-Asian |
8.753800E-01 |
| AfricanAmerican-vs-Asian |
1.796600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.25590000000531E-05 |
| Normal-vs-Female |
9.52840000000288E-05 |
| Male-vs-Female |
4.821200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.631600E-04 |
| Normal-vs-Age(41-60Yrs) |
2.11829999999802E-05 |
| Normal-vs-Age(61-80Yrs) |
2.45879999999365E-05 |
| Normal-vs-Age(81-100Yrs) |
3.130300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.820200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.799600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.706800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.944200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.550600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.183800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.094000E-02 |
| Classical-VS-Follicular |
1.033850E-01 |
| Classical-VS-Other |
6.758600E-01 |
| Classical-VS-Normal |
5.365900E-04 |
| Tall-VS-Follicular |
2.494200E-01 |
| Tall-VS-Other |
3.927800E-01 |
| Tall-VS-Normal |
3.3376000000418E-06 |
| Follicular-VS-Other |
9.021600E-01 |
| Follicular-VS-Normal |
7.53730000000452E-05 |
| Other-VS-Normal |
9.648500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.14519999999219E-05 |
| Normal-vs-N1 |
2.849100E-04 |
| N0-vs-N1 |
8.565200E-01 |
|
|
